S
Stane
Customized and tailored medical care services for patients, handled by professionals, allowing for focus on patient needs, project management, and transparency
About Stane
Stane Groupe, established in 2019 by co-founders Tiphanie Perre and Mehdi Djelamani, operates as a mission-driven company focused on integrating clinical research into community-based healthcare settings throughout France. The founders, both trained osteopaths, identified a critical gap in the healthcare system after their own experience attempting to launch a multi-professional health center. This firsthand knowledge of the operational, financial, and technical hurdles faced by healthcare professionals informs the company's core mission.
The company's business model is structured around four main pillars: stane ingénierie (engineering), stane invest (investment), stane services, and stane lab. This structure allows them to offer end-to-end support for healthcare facilities, from territorial audits and financial planning to construction and operational management. Revenue is generated by providing these specialized services to a diverse client base that includes healthcare professionals, local authorities, private real estate developers, and health-tech startups. A key part of their offering is alleviating the administrative and regulatory burdens associated with establishing and running both healthcare facilities and clinical trials.
Stane's primary service is facilitating decentralized clinical trials by connecting study sponsors—such as pharmaceutical labs, public institutions, and health project leaders—with its extensive network. This network comprises over 3,000 affiliated healthcare professionals and more than 1,000 active investigators across 150+ care facilities. This approach aims to make clinical research more representative of the general population by moving it out of hospitals, where 95% of research is traditionally concentrated, and into the community practices where patients receive daily care. To support this, Stane has developed staneResearch, a digital platform, and staneEDS, a secure health data warehouse validated by the French data protection authority (CNIL). These tools connect study promoters with investigators and streamline the entire research process.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Lyon, France
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 58.2/100
- Industry
- Health, Enterprise Software
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, observatoire healthtech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Sep 2023 | $11M | $44M | Mutuelles Impact · Siparex | ↗ |
Growth signals
Latest recorded traffic for Stane is 2.2K monthly website visits, up 175% over the last three months. Stane's team declined 2.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Mutuelles Impact
Siparex
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Stane on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Stane’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







